Gutzler, C., Höhne, K., Bani, D., Kayser, G., Fähndrich, S. W., Ambros, M., . . . Frye, B. C. (2025). Vasoactive Intestinal Peptide (VIP) in COVID-19 Therapy-Shedding of ACE2 and TMPRSS2 via ADAM10. International journal of molecular sciences, 26(6), . https://doi.org/10.3390/ijms26062666
Chicago-Zitierstil (17. Ausg.)Gutzler, Charlotte, et al. "Vasoactive Intestinal Peptide (VIP) in COVID-19 Therapy-Shedding of ACE2 and TMPRSS2 via ADAM10." International Journal of Molecular Sciences 26, no. 6 (2025). https://doi.org/10.3390/ijms26062666.
MLA-Zitierstil (9. Ausg.)Gutzler, Charlotte, et al. "Vasoactive Intestinal Peptide (VIP) in COVID-19 Therapy-Shedding of ACE2 and TMPRSS2 via ADAM10." International Journal of Molecular Sciences, vol. 26, no. 6, 2025, https://doi.org/10.3390/ijms26062666.